Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes

References

• TrepoC, ChanHL, LokA. Chronic hepatitis B virus infection. Lancet 384, 2053–2063 (2014).
   PubMed Web of Science ®Google Scholar
• McMahonBJ. The natural history of chronic hepatitis B virus infection. Hepatology 49(S5), S45–S55 (2009).
   PubMed Web of Science ®Google Scholar
• SchweitzerA, HornJ, MikolajczykRT, KrauseG, OttJJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386(10003), 1546–1555 (2015).
   PubMed Web of Science ®Google Scholar
• El-SeragHB, RudolphKL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7), 2557–2576 (2007).
   PubMed Web of Science ®Google Scholar
• MacLachlanJH, CowieBC. Hepatitis B virus epidemiology. Cold Spring Harb. Perspect. Med. 5(5), 1–24(2015).
   Web of Science ®Google Scholar
• ParkinDM, PisaniP, FerlayJ. Global cancer statistics. CA Cancer J. Clin. 49(1), 33–64 (1999).
   PubMed Web of Science ®Google Scholar
• BeasleyRP, HwangL-Y, LinC-C, ChienC-S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2(8256), 1129–1133 (1981).
   PubMed Web of Science ®Google Scholar
• FattovichG, BortolottiF, DonatoF. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 48(2), 335–352 (2008).
   PubMed Web of Science ®Google Scholar
• RaffettiE, FattovichG, DonatoF. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis. Liver Int. 36(9), 1239–1251 (2016).
   PubMed Web of Science ®Google Scholar
• LiawY-F, SungJJY, ChowWCet al.Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Engl. J. Med. 15(351), 1521–1531 (2004).
   Google Scholar
• EunJR, LeeHJ, KimTN, LeeKS. Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease. J. Hepatol. 53(1), 118–125 (2010).
   PubMed Web of Science ®Google Scholar
• HosakaT, SuzukiF, KobayashiMet al.Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 58(1), 98–107 (2013).
   PubMed Web of Science ®Google Scholar
• KimWR, LoombaR, BergTet al.Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Cancer 121(20), 3631–3638 (2015).
   PubMed Web of Science ®Google Scholar
• PapatheodoridisGV, LamperticoP, ManolakopoulosS, LokA. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J. Hepatol. 53(2), 348–356 (2010).
   PubMed Web of Science ®Google Scholar
• ShinnBJ, MartinA, CobenRMet al.Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: the need for hepatitis B virus cure. World J. Hepatol. 11(1), 65–73 (2019).
   PubMed Web of Science ®Google Scholar
• DarganA, WongSY, CobenR, ConnM, DimarinoAJ, HannHW. Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression. Minerva Gastroenterol. Dietol. 63(1), 74–76 (2017).
   PubMedGoogle Scholar
• LiangTJ. Hepatitis B: the virus and disease. Hepatology 49(5), S13–S21 (2009).
   PubMed Web of Science ®Google Scholar
• HoofnagleJH, DooE, LiangTJ, FleischerR, LokASF. Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4), 1056–1075 (2007).
   PubMed Web of Science ®Google Scholar
• YuMW, YehSH, ChenPJet al.Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J. Natl Cancer Inst. 97(4), 265–272 (2005).
   PubMed Web of Science ®Google Scholar
• KaoJH, ChenPJ, LaiMY, ChenDS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124(2), 327–334 (2003).
   PubMed Web of Science ®Google Scholar
• YimHJ, LokASF. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(S1), S173–S181 (2006).
   PubMedGoogle Scholar
• DandriM, LocarniniS. New insight in the pathobiology of hepatitis B virus infection. Gut 61, i6–i17 (2012).
   PubMed Web of Science ®Google Scholar
• ChidaY, HamerM, WardleJ, SteptoeA. Do stress-related psychosocial factors contribute to cancer incidence and survival?Nat. Clin. Pract. Oncol. 5(8), 466–475 (2008).
   PubMedGoogle Scholar
• VereCC, Teodor-StrebaC, StrebaLM, IonescuAG, SimaF. Psychosocial stress and liver disease status. World J. Gastroenterol. 15(24), 2980–2986 (2009).
   PubMed Web of Science ®Google Scholar
• BlockP, ShinnB, RothC, NeedlemanL, RosatoE, HannH-W. Vagaries of the host response in the development of hepatitis B-related hepatocellular carcinoma: a case series. Curr. Cancer Ther. Rev. Vol 3, 16 (2020).
   Google Scholar
• ChrousosGP, GoldPW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 267(9), 1244–1252 (1992).
   PubMed Web of Science ®Google Scholar
• Cichoż-LachH, MichalakA. Oxidative stress as a crucial factor in liver diseases. World J. Gastroenterol. 20(25), 8082–8091 (2014).
   PubMed Web of Science ®Google Scholar
• LiS, HongM, TanHY, WangN, FengY. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid. Med. Cell. Longev. 2016, 1–21 (2016).
   Web of Science ®Google Scholar
• MaX, HuaJ, MohamoodAR, HamadARA, RaviR, LiZ. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46(5), 1519–1529 (2007).
   PubMed Web of Science ®Google Scholar
• OoYH, WestonCJ, LalorPFet al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 184(6), 2886–2898 (2010).
   PubMed Web of Science ®Google Scholar
• ResheqYJ, LiK-K, WardSTet al.Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism of myeloid-derived suppressor cell induction operating in human hepatic stellate cells. J. Immunol. 194(6), 2578–2586 (2015).
   PubMed Web of Science ®Google Scholar
• LeeJ, FrenchB, MorganT, FrenchSW. The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2. Exp. Mol. Pathol. 96(1), 118–125 (2014).
   PubMed Web of Science ®Google Scholar
• BonnerMY, ArbiserJL. The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer. Future Med. Chem. 6(12), 1413–1422 (2014).
   PubMed Web of Science ®Google Scholar
• WangY, XiongJ, NiuMet al.Statins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studies. Oncotarget 8(35), 59666–59676 (2017).
   PubMedGoogle Scholar
• WanS, HuangC, ZhuX. Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients. BMJ Open. 9(7), 1–20(2019).
   PubMed Web of Science ®Google Scholar
• LamP, CheungF, TanHY, WangN, YuenMF, FengY. Hepatoprotective effects of Chinese medicinal herbs: a focus on anti-inflammatory and anti-oxidative activities. Int. J. Mol. Sci. 17(4), 1–37(2016).
   Web of Science ®Google Scholar
• RussTC, KivimäkiM, MorlingJR, StarrJM, StamatakisE, BattyGD. Association between psychological distress and liver disease mortality: a meta-analysis of individual study participants. Gastroenterology 148(5), 958–966.e4 (2015).
   PubMed Web of Science ®Google Scholar
• BonkovskyHL. On stress and the liver: a chicken and egg conundrum. Gastroenterology 148(5), 894–897 (2015).
   PubMed Web of Science ®Google Scholar
• JoungJY, ChoJH, KimYH, ChoiSH, SonCG. A literature review for the mechanisms of stress-induced liver injury. Brain Behav. 9(3), 1–8 (2019).
   Web of Science ®Google Scholar
• ChrousosGP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332(20), 1351–1363 (1995).
   PubMed Web of Science ®Google Scholar
• KimYK, MaesM. The role of the cytokine network in psychological stress. Acta Neuropsychiatr. 15(3), 148–155 (2003).
   PubMed Web of Science ®Google Scholar
• MoynihanJA. Mechanisms of stress-induced modulation of immunity. Brain Behav. Immun. 17, S11–S16 (2003).
   PubMed Web of Science ®Google Scholar
• McewenBS, GianarosPJ. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann. N Y Acad. Sci. 1186, 190–222 (2010).
   PubMed Web of Science ®Google Scholar
• BortolatoB, HyphantisTN, ValpioneSet al.The many biobehavioral pathways driving tumor progression. Cancer Treat. Rev. 52, 58–70 (2017).
   PubMed Web of Science ®Google Scholar
• HowrenMB, LamkinDM, SulsJ. Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71(2), 171–186 (2009).
   PubMed Web of Science ®Google Scholar
• DowlatiY, HerrmannN, SwardfagerWet al.A meta-analysis of cytokines in major depression. Biol. Psychiatry 67(5), 446–457 (2010).
   PubMed Web of Science ®Google Scholar
• LiuY, HoRCM, MakA. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 139(3), 230–239 (2012).
   PubMed Web of Science ®Google Scholar
• ScanzanoA, CosentinoM. Adrenergic regulation of innate immunity: a review. Front. Pharmacol. Vol 171, 6 (2015).
   Google Scholar
• YangLJ, LiuX, LiuDXet al.Effects of different adrenergic blockades on the stress resistance of Wistar rats. Neurosci. Lett. 511(2), 95–100 (2012).
   PubMed Web of Science ®Google Scholar
• ZhouM, YangS, KooDJ, OrnanDA, ChaudryIH, WangP. The role of Kupffer cell α2-adrenoceptors in norepinephrine-induced TNF-α production. Biochim. Biophys. Acta, Mol. Basis Dis. 1537(1), 49–57 (2001).
   Web of Science ®Google Scholar
• JungBD, KimuraE, KitamuraHet al.Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes. J. Biochem. 127(2), 205–210 (2000).
   PubMed Web of Science ®Google Scholar
• PaceTWW, MletzkoTC, AlagbeOet al.Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 163(9), 1630–1633 (2006).
   PubMed Web of Science ®Google Scholar
• GongY, ChaiY, DingJH, SunXL, HuG. Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain. Neurosci. Lett. 488(1), 76–80 (2011).
   PubMed Web of Science ®Google Scholar
• MoylanS, MaesM, WrayNR, BerkM. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry. 18(5), 595–606 (2013).
   PubMed Web of Science ®Google Scholar
• GanemD, PrinceAM. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350, 1118–1129 (2004).
   PubMed Web of Science ®Google Scholar
• BauerT, SprinzlM, ProtzerU. Immune control of hepatitis B virus. Dig. Dis. 29(4), 423–433 (2011).
   PubMed Web of Science ®Google Scholar
• ZhangZ, ZhangJY, WangLF, WangFS. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 27(2), 223–230 (2012).
   PubMed Web of Science ®Google Scholar
• MomeniM, ZainodiniN, BidakiRet al.Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients. Hum. Immunol. 75(1), 15–19 (2014).
   PubMed Web of Science ®Google Scholar
• RatnamDT, SievertW, VisvanathanK. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B. Cell. Immunol. 279(1), 109–115 (2012).
   PubMed Web of Science ®Google Scholar
• vander Molen RG, SprengersD, BindaRSet al.Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40(3), 738–746 (2004).
   PubMed Web of Science ®Google Scholar
• LiT-Y, YangY, ZhouG, TuZ-K. Immune suppression in chronic hepatitis B infection associated liver disease: a review. World J. Gastroenterol. 25(27), 3527–3537 (2019).
   PubMed Web of Science ®Google Scholar
• YeB, LiuX, LiX, KongH, TianL, ChenY. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 6, e1694 (2015).
   PubMed Web of Science ®Google Scholar
• LopesAR, KellamP, DasAet al.Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection. J. Clin. Invest. 118(5), 1835–1845 (2008).
   PubMed Web of Science ®Google Scholar
• XuD, FuJ, JinLet al.Circulating and liver resident CD4 + CD25 + regulatory t cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177(1), 739–747 (2006).
   PubMed Web of Science ®Google Scholar
• DasA, HoareM, DaviesNet al.Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205(9), 2111–2124 (2008).
   PubMed Web of Science ®Google Scholar
• RingelhanM, O’ConnorT, ProtzerU, HeikenwalderM. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J. Pathol. 235(2), 355–367 (2015).
   PubMed Web of Science ®Google Scholar
• AnP, XuJ, YuY, WinklerCA. Host and viral genetic variation in HBV-related hepatocellular carcinoma. Front. Genet. 9(261), 1–15 (2018).
   PubMedGoogle Scholar
• BlockTM, GuoH, GuoJT. Molecular virology of hepatitis B virus for clinicians. Clin. Liver Dis. 11(4), 685–706 (2007).
   PubMedGoogle Scholar
• VandevenN, NghiemP. Pathogen-driven cancers and emerging immune therapeutic strategies. Cancer Immunol. Res. 2(1), 9–14 (2014).
   PubMed Web of Science ®Google Scholar
• WeberA, BogerR, VickIet al.Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 51(4), 1226–1236 (2010).
   PubMed Web of Science ®Google Scholar
• XiaoM, ChenW, WangCet al.Senescence and cell death in chronic liver injury: roles and mechanisms underlying hepatocarcinogenesis. Oncotarget 9(9), 8772–8784 (2018).
   PubMedGoogle Scholar
• PikarskyE, PoratRM, SteinIet al.NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431(7007), 461–466 (2004).
   PubMed Web of Science ®Google Scholar
• LueddeT, SchwabeRF. NF-κB in the liver: linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 8(2), 108–118 (2011).
   PubMed Web of Science ®Google Scholar
• HuangX, LiuX, YuY. Depression and chronic liver diseases: are there shared underlying mechanisms?Front. Mol. Neurosci. 10(8), 1–36(2017).
   PubMedGoogle Scholar
• AltindagA, CadirciD, SirmatelF. Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers. Neurosciences (Riyadh) 14(1), 56–59 (2009).
   PubMed Web of Science ®Google Scholar
• HazavehMM, ToosiTD, ToosiMN, TavakoliA, ShahbaziF. Prevalence and severity of depression in chronic viral hepatitis in Iran. Gastroenterol. Rep. 3(3), 234–237 (2015).
   Google Scholar
• HannHW, HanSH, BlockTMet al.Symptomatology and health attitudes of chronic hepatitis B patients in the USA. J. Viral Hepat. 15(1), 42–51 (2008).
   PubMed Web of Science ®Google Scholar
• AtesciFC, CetinBC, OguzhanogluNK, KaradagF, TurgutH. Psychiatric disorders and functioning in hepatitis B virus carriers. Psychosomatics 46(2), 142–147 (2005).
   PubMed Web of Science ®Google Scholar
• SiewCO, MakB, MyatOA, LiSC, LimSG. Health-related quality of life in chronic hepatitis B patients. Hepatology 47(4), 1108–1117 (2008).
   PubMed Web of Science ®Google Scholar
• HannHW, MeyerJ, ParkG, BlockPD, JuonH-S. Hair cortisol and chronic stress exposure in chronic Hepatitis B. Clin. Invest. 9(4), 121–127 (2019).
   Google Scholar
• KunkelEJS, SungKim J, HannHWet al.Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics 41(6), 472–480 (2002).
   Web of Science ®Google Scholar
• AnsteadMI, HuntTA, CarlsonSL, BurkiNK. Variability of peripheral blood lymphocyte beta-2-adrenergic receptor density in humans. Am. J. Respir. Crit. Care Med. 157(3 Pt I), 990–992 (1998).
   PubMed Web of Science ®Google Scholar
• MaiselAS, FowlerP, ReardenA, MotulskyHJ, MichelMC. A new method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 46(4), 429–439 (1989).
   PubMed Web of Science ®Google Scholar
• FleshnerM, LaudenslagerML. Psychoneuroimmunology: then and now. Behav. Cogn. Neurosci. Rev. 3(2), 114–130 (2004).
   PubMedGoogle Scholar
• HeYL, GaoH, LiXM, ZhaoYR. Psychological stress exerts effects on pathogenesis of hepatitis B via type-1/type-2 cytokines shift toward type-2 cytokine response. PLoS ONE 9(8), e105530 (2014).
   PubMed Web of Science ®Google Scholar
• GreenMcdonald P, O’connellM, LutgendorfSK. A decade of discovery, paradigm shifts, and methodological innovations. Brain Behav. Immun. 30, S1–S9 (2013).
   PubMed Web of Science ®Google Scholar
• KikuchiN, NishiyamaT, SawadaTet al.Perceived stress and colorectal cancer incidence: the Japan collaborative cohort study. Sci. Rep. Vol 7, 7 (2017).
   Web of Science ®Google Scholar
• SongH, SaitoE, SawadaNet al.Perceived stress level and risk of cancer incidence in a Japanese population: the Japan Public Health Center (JPHC)-based prospective study. Sci. Rep. 7(1), 1–16 (2017).
   PubMed Web of Science ®Google Scholar
• Giese-DavisJ, CollieK, RancourtKMS, NeriE, KraemerHC, SpiegelD. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J. Clin. Oncol. 29(4), 413–420 (2011).
   PubMed Web of Science ®Google Scholar
• LutgendorfSK, DeGeest K, BenderDet al.Social influences on clinical outcomes of patients with ovarian cancer. J. Clin. Oncol. 30(23), 2885–2890 (2012).
   PubMed Web of Science ®Google Scholar
• KennedyB, FangF, ValdimarsdóttirU, UdumyanR, MontgomeryS, FallK. Stress resilience and cancer risk: a nationwide cohort study. J. Epidemiol. Community Health 71(10), 947–953 (2017).
   PubMed Web of Science ®Google Scholar
• BertolettiA, FerrariC. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61(12), 1754–1764 (2012).
   PubMed Web of Science ®Google Scholar
• LiangTJ, BlockTM, McMahonBJet al.Present and future therapies of hepatitis B: from discovery to cure. Hepatology 62(6), 1893–1908 (2015).
   PubMed Web of Science ®Google Scholar